List view / Grid view

PCI Pharma Services

 

article

Precision medicine for complex chronic diseases: how near are we?

28 April 2022 | By , ,

Targeting medicines against the genetic and molecular drivers of lung, breast and other tumours has helped transform cancer care for many patients, yet precision medicine for complex chronic diseases has lagged behind. Maria Orr, Adam Platt and Ben Challis, from BioPharmaceuticals R&D at AstraZeneca, explain why this is changing for…

content_hub

PCI Pharma Services

20 January 2022 | By

PCI is a leading global CDMO, providing clients with integrated end-to-end drug development, manufacturing and packaging capabilities.